Measuring adiposity in patients: the utility of body mass index (BMI), percent body fat, and leptin von Shah, Nirav R, Braverman, Eric R

Volltext

Documenting Penicillin Allergy: The Impact of Inconsistency von Shah, Nirav S, Ridgway, Jessica P, Pettit, Natasha, Fahrenbach, John, Robicsek, Ari

Volltext

Is There Still a Role for Allogeneic Transplantation in the Management of Lymphoma? von Shah, Nirav N, Hamadani, Mehdi

Volltext

Multispecific CAR T Cells Deprive Lymphomas of Escape via Antigen Loss von Furqan, Fateeha, Shah, Nirav N

Volltext

Uses of Electronic Health Records for Public Health Surveillance to Advance Public Health von Birkhead, Guthrie S, Klompas, Michael, Shah, Nirav R

Volltext

Multi Targeted CAR-T Cell Therapies for B-Cell Malignancies von Shah, Nirav N, Maatman, Theresa, Hari, Parameswaran, Johnson, Bryon

Volltext

Ruxolitinib for the treatment of steroid-refractory acute GVHD (REACH1): a multicenter, open-label phase 2 trial von Jagasia, Madan, Perales, Miguel-Angel, Schroeder, Mark A., Ali, Haris, Shah, Nirav N., Chen, Yi-Bin, Fazal, Salman, Dawkins, Fitzroy W., Arbushites, Michael C., Tian, Chuan, Connelly-Smith, Laura, Howell, Michael D., Khoury, H. Jean

Volltext

Pirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN): a phase 1/2 study von Mato, Anthony R, Shah, Nirav N, Jurczak, Wojciech, Cheah, Chan Y, Pagel, John M, Woyach, Jennifer A, Fakhri, Bita, Eyre, Toby A, Lamanna, Nicole, Patel, Manish R, Alencar, Alvaro, Lech-Maranda, Ewa, Wierda, William G, Coombs, Catherine C, Gerson, James N, Ghia, Paolo, Le Gouill, Steven, Lewis, David John, Sundaram, Suchitra, Cohen, Jonathon B, Flinn, Ian W, Tam, Constantine S, Barve, Minal A, Kuss, Bryone, Taylor, Justin, Abdel-Wahab, Omar, Schuster, Stephen J, Palomba, M Lia, Lewis, Katharine L, Roeker, Lindsey E, Davids, Matthew S, Tan, Xuan Ni, Fenske, Timothy S, Wallin, Johan, Tsai, Donald E, Ku, Nora C, Zhu, Edward, Chen, Jessica, Yin, Ming, Nair, Binoj, Ebata, Kevin, Marella, Narasimha, Brown, Jennifer R, Wang, Michael

Volltext

CAR T-cell therapy for secondary CNS DLBCL von Ahmed, Gulrayz, Hamadani, Mehdi, Shah, Nirav N.

Volltext

Allogeneic transplant following CAR T-cell therapy for large B-cell lymphoma von Zurko, Joanna, Ramdial, Jeremy, Shadman, Mazyar, Ahmed, Sairah, Szabo, Aniko, Iovino, Lorenzo, Tomas, Ana Alarcon, Sauter, Craig, Perales, Miguel-Angel, Shah, Nirav N, Acharya, Utkarsh H, Jacobson, Caron, Soiffer, Robert J, Wang, Trent, Komanduri, Krishna V, Jaglowski, Samantha, Kittai, Adam S, Denlinger, Nathan, Iqbal, Madiha, Kharfan-Dabaja, Mohamed A, Ayala, Ernesto, Chavez, Julio, Jain, Michael, Locke, Frederick L, Samara, Yazeed, Budde, Lihua E, Mei, Matthew G, Pia, Alexandra Della, Feldman, Tatyana, Ahmed, Nausheen, Jacobs, Ryan, Ghosh, Nilanjan, Dholaria, Bhagirathbhai, Oluwole, Olalekan O, Hess, Brian, Hassan, Ayesha, Kenkre, Vaishalee P, Reagan, Patrick, Awan, Farrukh, Nieto, Yago, Hamadani, Mehdi, Herrera, Alex F

Volltext

Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar Study von Cutler, Corey, Lee, Stephanie J., Arai, Sally, Rotta, Marcello, Zoghi, Behyar, Lazaryan, Aleksandr, Ramakrishnan, Aravind, DeFilipp, Zachariah, Salhotra, Amandeep, Chai-Ho, Wanxing, Mehta, Rohtesh, Wang, Trent, Arora, Mukta, Pusic, Iskra, Saad, Ayman, Shah, Nirav N., Abhyankar, Sunil, Bachier, Carlos, Galvin, John, Im, Annie, Langston, Amelia, Liesveld, Jane, Juckett, Mark, Logan, Aaron, Schachter, Levanto, Alavi, Asif, Howard, Dianna, Waksal, Harlan W., Ryan, John, Eiznhamer, David, Aggarwal, Sanjay K., Ieyoub, Jonathan, Schueller, Olivier, Green, Laurie, Yang, Zhongming, Krenz, Heidi, Jagasia, Madan, Blazar, Bruce R., Pavletic, Steven

Volltext

Bispecific anti-CD20, anti-CD19 CAR T cells for relapsed B cell malignancies: a phase 1 dose escalation and expansion trial von Shah, Nirav N., Johnson, Bryon D., Schneider, Dina, Zhu, Fenlu, Szabo, Aniko, Keever-Taylor, Carolyn A., Krueger, Winfried, Worden, Andrew A., Kadan, Michael J., Yim, Sharon, Cunningham, Ashley, Hamadani, Mehdi, Fenske, Timothy S., Dropulić, Boro, Orentas, Rimas, Hari, Parameswaran

Volltext

Impact of Social Needs Navigation on Utilization Among High Utilizers in a Large Integrated Health System: a Quasi-experimental Study von Schickedanz, Adam, Sharp, Adam, Hu, Yi R., Shah, Nirav R., Adams, John L., Francis, Damon, Rogers, Artair

Volltext

Silent hypoxia: A harbinger of clinical deterioration in patients with COVID-19 von Wilkerson, R. Gentry, Adler, Jason D., Shah, Nirav G., Brown, Robert

Volltext

National Marrow Donor Program-Sponsored Multicenter, Phase II Trial of HLA-Mismatched Unrelated Donor Bone Marrow Transplantation Using Post-Transplant Cyclophosphamide von Shaw, Bronwen E, Jimenez-Jimenez, Antonio Martin, Burns, Linda J, Logan, Brent R, Khimani, Farhad, Shaffer, Brian C, Shah, Nirav N, Mussetter, Alisha, Tang, Xiao-Ying, McCarty, John M, Alavi, Asif, Farhadfar, Nosha, Jamieson, Katarzyna, Hardy, Nancy M, Choe, Hannah, Ambinder, Richard F, Anasetti, Claudio, Perales, Miguel-Angel, Spellman, Stephen R, Howard, Alan, Komanduri, Krishna V, Luznik, Leo, Norkin, Maxim, Pidala, Joseph A, Ratanatharathorn, Voravit, Confer, Dennis L, Devine, Steven M, Horowitz, Mary M, Bolaños-Meade, Javier

Volltext

Parenthood and Paychecks—The Gender Pay Gap in Medicine von Kim, Kyung Mi, Narayan, Aditya, Shah, Nirav R, Milstein, Arnold

Volltext

High-throughput in vivo screen of functional mRNA delivery identifies nanoparticles for endothelial cell gene editing von Sago, Cory D., Lokugamage, Melissa P., Paunovska, Kalina, Vanover, Daryll A., Monaco, Christopher M., Shah, Nirav N., Castro, Marielena Gamboa, Anderson, Shannon E., Rudoltz, Tobi G., Lando, Gwyneth N., Tiwari, Pooja Mummilal, Kirschman, Jonathan L., Willett, Nick, Jang, Young C., Santangelo, Philip J., Bryksin, Anton V., Dahlman, James E.

Volltext

Supramolecular design of self-assembling nanofibers for cartilage regeneration von Shah, Ramille N, Shah, Nirav A, Del Rosario Lim, Marc M, Hsieh, Caleb, Nuber, Gordon, Stupp, Samuel I

Volltext

Is autologous transplant in relapsed DLBCL patients achieving only a PET+ PR appropriate in the CAR T-cell era? von Shah, Nirav N., Ahn, Kwang W., Litovich, Carlos, He, Yizeng, Sauter, Craig, Fenske, Timothy S., Hamadani, Mehdi

Volltext

CAR T-cell therapy for B-cell lymphomas: outcomes and resistance mechanisms von Kearl, Tyce J., Furqan, Fateeha, Shah, Nirav N.

Volltext